Premium
Chemical stiffening of constructs between polymeric microparticles based on a hyaluronic acid derivative and mesenchymal stem cells: rheological and in vitro viability studies
Author(s) -
Palumbo Fabio S,
Agnello Stefano,
Fiorica Calogero,
Pitarresi Giovanna,
Giammona Gaetano
Publication year - 2019
Publication title -
polymer international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.592
H-Index - 105
eISSN - 1097-0126
pISSN - 0959-8103
DOI - 10.1002/pi.5722
Subject(s) - hyaluronic acid , stiffening , mesenchymal stem cell , tissue engineering , rheology , viability assay , materials science , adhesive , dynamic mechanical analysis , in vitro , adhesion , chemical engineering , chemistry , polymer chemistry , biomedical engineering , biophysics , polymer , nanotechnology , composite material , biochemistry , microbiology and biotechnology , layer (electronics) , biology , anatomy , medicine , engineering
Our research group has recently developed microparticles of a hyaluronic acid derivative used for bottom‐up growth of microparticles/human mesenchymal stem cells (hMSCs). In this work, we investigated a strategy to increase the stiffening of aggregated constructs between microparticles and hMSCs. In particular, we applied a Michael‐type crosslinking procedure between microparticles to allow a chemically driven and cell‐compatible stiffening of constructs. Two batches of microparticles were functionalized with thiol and maleimide groups, respectively, and were then mixed to allow chemical crosslinking. The adhesion of hMSCs was controlled through addition of the adhesive peptide cyclo(‐Arg‐Gly‐Asp‐D‐Phe‐Cys) (cyRGDC). Rheological measurements performed in this study showed that the chemical stiffening strategy allows the G ′ modulus of bottom‐up growing constructs to be increased, while viability tests suggest that the chemical procedure did not negatively affect cell viability compared with constructs obtained without chemical crosslinking. © 2018 Society of Chemical Industry